Frontline Lenalidomide for AL Amyloidosis Involving Myocardium
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This phase II clinical trial aimed at influencing the improvement of major organ functions,
especially the objective response rate, in Amyloid light-chain amyloidosis involving
myocardium.